PLAUR and neoplasm: A patient with stage III and uPAR-positive macrophages/tumor core and high uPAR(I) level had a 12-fold (95% CI: 9.3–15.4) higher hazard than a patient in stage II with negative macrophage/tumor core score and a low uPAR(I) level.